| pubmed-article:18445640 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0025926 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0027697 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
| pubmed-article:18445640 | lifeskim:mentions | umls-concept:C0443211 | lld:lifeskim |
| pubmed-article:18445640 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:18445640 | pubmed:dateCreated | 2008-8-19 | lld:pubmed |
| pubmed-article:18445640 | pubmed:abstractText | Rapamycin is a potent immunosuppressive drug with proven efficacy in rejection prophylaxis in solid organ transplantation. By virtue of its immunosuppressive properties, rapamycin might also be useful in the treatment of autoimmune diseases. The aim of this study was to determine the effect of rapamycin on the severity of established nephritis in lupus-prone New Zealand Black/White F(1) (NZB/W F(1)) mice. | lld:pubmed |
| pubmed-article:18445640 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18445640 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18445640 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18445640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18445640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18445640 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18445640 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18445640 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:18445640 | pubmed:issn | 1460-2385 | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:LuiSing... | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:ChanTak MaoTM | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:ChanKwok... | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:YungSusanS | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:TamSidneyS | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:TsangRyanR | lld:pubmed |
| pubmed-article:18445640 | pubmed:author | pubmed-author:ZhangFlorence... | lld:pubmed |
| pubmed-article:18445640 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18445640 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:18445640 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18445640 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18445640 | pubmed:pagination | 2768-76 | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:meshHeading | pubmed-meshheading:18445640... | lld:pubmed |
| pubmed-article:18445640 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18445640 | pubmed:articleTitle | Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. | lld:pubmed |
| pubmed-article:18445640 | pubmed:affiliation | Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, People's Republic of China. | lld:pubmed |
| pubmed-article:18445640 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18445640 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18445640 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18445640 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18445640 | lld:pubmed |
